Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Dose Optimization and Targeting Strategies of Anti-infective Agents"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 6904
Special Issue Editors
Interests: pharmacokinetics; therapeutic drug monitoring; pharmacometrics; clinical pharmacology
Interests: pharmacokinetics; pharmacogenomics; clinical pharmacology, clinical trials
Special Issue Information
Most drugs are currently developed, approved and marketed based on their effect in the majority of the population. However, the concept of a single dose of a drug for all patients with the same disease may not lead to the desired results. As a result of inter-individual variability in population, the concentration profile of the drug over time after administration of the same dose to individual patients may vary significantly. The same dose may thus lead to signs of toxicity in some patients, while in others may be ineffective. In addition, for anti-infective agents, low exposure may be accompanied by the development of resistance. In order to achieve maximum therapeutic potential of anti-infective drugs the therapy needs to be targeted and dosage optimized. Therefore, this special issue aims to serve as a platform for sharing the contemporary progress on dose optimization and targeting strategies of antibiotics as well as other anti-infective agents. We cordially invite researchers for submission of original research articles, review articles or commentaries on all aspects of this topic.
Dr. Martin Šíma
Prof. Dr. Ondřej Slanař
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- therapeutic drug monitoring
- personalized pharmacotherapy
- modeling and simulation